Heritage Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Hold |
28
| – | – | ﹤0.01% | 403 |
|
|
2025
Q1 | $17.8K | Sell |
28
-29
| -51% | -$18.4K | ﹤0.01% | 379 |
|
|
2024
Q4 | $40.6K | Sell |
57
-4
| -7% | -$2.85K | ﹤0.01% | 330 |
|
|
2024
Q3 | $64.1K | Buy |
61
+3
| +5% | +$3.15K | ﹤0.01% | 310 |
|
|
2024
Q2 | $61K | Hold |
58
| – | – | ﹤0.01% | 294 |
|
|
2024
Q1 | $55.8K | Sell |
58
-50
| -46% | -$48.1K | ﹤0.01% | 315 |
|
|
2023
Q4 | $94.9K | Hold |
108
| – | – | ﹤0.01% | 272 |
|
|
2023
Q3 | $88.9K | Hold |
108
| – | – | ﹤0.01% | 261 |
|
|
2023
Q2 | $77.6K | Sell |
108
-3
| -3% | -$2.16K | ﹤0.01% | 280 |
|
|
2023
Q1 | $91.2K | Sell |
111
-20
| -15% | -$16.4K | 0.01% | 266 |
|
|
2022
Q4 | $94.5K | Buy |
131
+81
| +162% | +$58.4K | 0.01% | 268 |
|
|
2022
Q3 | $34.4K | Hold |
50
| – | – | ﹤0.01% | 331 |
|
|
2022
Q2 | $30K | Hold |
50
| – | – | ﹤0.01% | 375 |
|
|
2022
Q1 | $35K | Hold |
50
| – | – | ﹤0.01% | 350 |
|
|
2021
Q4 | $32K | Hold |
50
| – | – | ﹤0.01% | 365 |
|
|
2021
Q3 | $30.3K | Buy |
+50
| New | +$30.3K | ﹤0.01% | 366 |
|